Purpose: This study looks at the safety and immune response of a new meningococcal vaccine for different age groups when given alone or with other vaccines.
Who can join? You may be eligible if:
- Age: If you are in the US: 10-25 years old. In the EU: 42-89 days old, 12-18 months old, or 10-50 years old.
- Health: You should be healthy, not pregnant, and able to follow study procedures.
- Insurance: You may need health insurance as per local rules.
Study details: The study lasts 7 to 18 months depending on the stage. It involves regular visits to check health and vaccine effects.
Key Points:
- Participation time is 7-18 months with multiple visits.
- Participants will receive either the investigational vaccine or licensed vaccines.
- Eligibility includes being in specified age ranges and healthy, with certain conditions for females.
Talk to your doctor if you're interested and see if you meet the criteria!
How understandable was the trial content above?
Hard to understand
Easy to understand
